Laurence Huang, MD

Phone: 415-476-4082 ext. 406
UCSF Box: 0874
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start
End
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis University of Colorado Denver, Anschutz Medical Campus Uganda HIV/AIDS, Tuberculosis
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study NIH National Heart, Lung, and Blood Institute Uganda HIV/AIDS, Chronic Respiratory Disease
Transcriptional alterations in bronchoalveolar lavage fluid during treatment of human tuberculosis. University of Colorado Denver, Anschutz Medical Campus United States Tuberculosis
Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes University of Pittsburgh United States Chronic Respiratory Disease
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases NIH National Heart, Lung, and Blood Institute Uganda HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV U of Colorado Denver/Anschutz Medical C United States HIV/AIDS, Chronic Respiratory Disease
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) University of Pittsburgh United States HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) University of Washington (UW) United States HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV University of Pittsburgh United States HIV/AIDS, Chronic Respiratory Disease
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study NIH National Heart, Lung, and Blood Institute United States HIV/AIDS
FIND Xpert MTB assay collaboration at Mulago Hospital Foundation for Innovative New Diagnostics Uganda Tuberculosis
International HIV-Associated Opportunistic Pneumonias (IHOP) Study NIH National Heart, Lung, and Blood Institute Uganda; United Kingdom; United States HIV/AIDS
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease University of Washington (UW) United States HIV/AIDS, Chronic Respiratory Disease
UCSF-FIND Uganda Project Foundation for Innovative New Diagnostics Uganda Tuberculosis, Drug and Diagnostics Development
International HIV-Associated Opportunistic Pneumonias (IHOP) Study NIH National Heart, Lung, and Blood Institute Uganda; United Kingdom HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Yale University United States HIV/AIDS
PCP OPW Specimens/Uganda Project Support NIH Warren Grant Magnuson Clinical Center Uganda Infectious Disease, HIV/AIDS, Opportunistic Infection
Patient-Oriented Research and Mentoring in Pneumocystis NIH National Heart, Lung, and Blood Institute Uganda
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Immtech Pharmaceuticals, Inc. United States HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Specimens Related to the MU-UCSF Research Collaboration Makerere University Uganda HIV/AIDS
Evaluate Serum-Based Assay for Pneumocystis Pneumonia Diagnosis U.S. Department of Veterans Affairs United States Chronic Respiratory Disease
Molecular Epidemiology of Human P. Carinii Pneumonia NIH National Heart, Lung, and Blood Institute United States
PCP OPW Specimens NIH Warren Grant Magnuson Clinical Center Uganda Opportunistic Infection